Applicant, as named in the Orange Book
Urogen Pharma
Next listed expiry: Jelmyto on 20 Jan 2031. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Jelmyto NDA 211728 mitomycin | 20 Jan 2031 patent |
| Zusduri NDA 215793 mitomycin | 25 Jul 2044 patent, carve-out possible |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.